Zirus Inc.
Industry
- Biotechnology
- Pharmaceuticals
- Vaccines
Latest on Zirus Inc.
With approval of direct-acting hepatitis C therapies just around the corner, start-ups are looking to provide parts of the puzzle in next-generation drug cocktails for treating the growing disease. Fo
Targeting genes viruses need, but humans don't 1384 Buford Business Boulevard Buford, GA 30518 Phone: (404) 863-6625 Web Site: www.zirus.net Contact: David Perryman, CEO Industry Segment: Biotechnolog
Start-Ups Look For A Place In HCV Combo Regimens In the four years since AiCuris GMBH & Co. KG spun out of Bayer HealthCare's anti-infectives unit, it has continued to advance its inherited pipeli
In Vitro Diagnostics Biomarker Factory Laboratory Corp. of America Holdings Duke University Duke University Medical Center Duke and LabCorp form biomarker joint venture April — Laboratory Corp. of A